*Mycobacterium bovis* Bacillus Calmette Guerin, commonly known as BCG, is the only vaccine against tuberculosis. The original BCG strain was obtained by serial passages of a *M. bovis* strain in potato-bile media.[@B1] Deletion of the region of difference (RD) 1 was later confirmed as one of the reasons for the attenuation of its virulence.[@B2] ^,^ [@B3] After its first use in humans, the vaccine was sent to different laboratories worldwide where different culturing conditions originated strains with different genetic compositions.[@B4]

At present, there are more than 10 different vaccine strains being administered worldwide.[@B5] In two countries in Latin-America, namely Venezuela and Argentina, the strains BCG Danish 1331 (Statens serum Institut, Denmark), BCG Pasteur 1173P2 (Instituto Nacional de Producción de Biológicos ― ANLIS Carlos G Malbrán, Argentina) and BCG Sofia SL222 (BB NCIPD Ltd, Bulgaria) are licensed for use. The vaccine BCG Pasteur produced in Argentina is a secondary seed lot of the French BCG Pasteur strain 1173P2 and is administered in the Province of Buenos Aires, while the rest of the country is vaccinated either with the Sofia or the Danish strain. In Brazil, BCG Moreau RDJ (Fundação Ataulpho de Paiva, Brazil) was used as a vaccine until 2017, when it was replaced by the Russian strain.

Whole genome sequencing data of the strains Moreau, Pasteur and Danish are already available[@B6] ^,^ [@B7] ^,^ [@B8] ^)^ and obtained either by using shotgun sequencing and specific primers designed to close the gaps in the assembly (for Moreau and Pasteur strains) or a combination of Illumina and PacBio technology (for the Danish strain). BCG Sofia has so far only been subjected to whole genome analysis using microarrays.[@B9] We sequenced the genome of these four vaccine strains with Illumina technology in an effort to update the sequencing data available and for BCG Sofia, we report the first sequence data obtained with newer technology.

Genome sequencing of the four vaccine strains was performed using the Nextera XT DNA Library preparation kit on an Illumina HiSeq 2500 platform. *De novo* assembly was done using Unicycler[@B10] and annotated with RAST.[@B11] To determine intra-strain genomic variability of each vaccine, we compared the genomes with previous assemblies obtained from the NCBI[@B6] ^,^ [@B7] ^,^ [@B8] using the software Artemis Comparison tool[@B12] and Snippy.[@B13] The strain BCG Sofia SL222 originated from the Russian vaccine BCG-1 and was chosen as a master seed at the BCG Bulgarian laboratory.[@B9] Because there is no whole genome assembly available for BCG Sofia SL222, we decided to use the assembly of its parental strain BCG-1 Russia for the comparative studies.[@B14]

Among the four genomes, we obtained between 82 and 108 contigs, an average guanine-cytosine content (GC) of 65%, a size ranging between 4.2 and 4.3 Mb and the number of coding sequences (CDS) between 4205 and 4245 ([Table I](#t1){ref-type="table"}). The differences in the size of BCG strains genomes we noticed when compared to those available in public databases is probably due to variation in sequencing technologies and of assemblers used.

TABLE IAssembly statistics for the four vaccine strains sequencedNumber of contigsMoreau RDJPasteur 1173P2Sofia SL222Danish 13318293102108Genome size (bp)4288.2454.192.5454.201.8894.202.807Coverage414X107X101X94X% GC65.6265.4865.4565.47N50197411844147069170718CDS4232420542454227tRNAs47474747[^2]

The genome of BCG Moreau RDJ strain revealed 55 single nucleotide polymorphisms (SNPs) compared to that of the shotgun sequencing based genome of the same strain obtained in 2011, 28 of these SNPs are non-synonymous (ns) ([Table II](#t2){ref-type="table"}). We also detected five insertions and four deletions of 3-4 nucleotides (data not shown) and an inverted IS1608 transposase gene (position 3717335-3717826 bp).

TABLE IINon-synonymous single nucleotide polymorphisms (SNPs) found in Bacillus Calmette Guerin (BCG) Moreau when using assembly NZ_AM412059^*\**^ as a referencePositionNZ_AM412059BCG MoreauAA changeGene404956TGGlu713AspIron-sulphur-binding reductase555536CTGly164GluFIG00821074: hypothetical protein555569GAPro153LeuFIG00821074: hypothetical protein570675TGLys91AsnAliphatic amidase AmiE878380GTGly233ValProtease II (EC 3.4.21.83)1217552TGHis65GlnPE family protein1618404AGAsp284GlyAnaerobic dimethyl sulfoxide reductase chain A1618472ACMet307LeuAnaerobic dimethyl sulfoxide reductase chain A1618722GCArg390ProAnaerobic dimethyl sulfoxide reductase chain A1618779TGVal409GlyAnaerobic dimethyl sulfoxide reductase chain A1731072GAAla234ThrSorbitol-6-phosphate 2-dehydrogenase1985896CGPro114AlaL-gulono-1,4-lactone oxidase2400116AGLeu184ProCell division protein FtsL / proline rich membrane protein2651260CGAla266GlyPE family protein2701298GTPro413ThrRibonuclease E2760281TCSer266GlyGTP-binding protein Obg2760610GCAla156GlyGTP-binding protein Obg2760682TCGlu132GlyGTP-binding protein Obg3149570CGLeu224ValCoenzyme F420-dependent oxidoreductase3273878AGVal602AlaATP-dependent DNA helicase RecG3365033ACTrp93GlyTranscriptional regulator, TetR family3809510CGGly67AlaFIG00820542: hypothetical protein3879667AGAsn344AspGTP-binding protein Obg3881120TGIle828SerGTP-binding protein Obg3881141CAThr835AsnGTP-binding protein Obg3891798TGAsp162AlaLong-chain fatty-acid-CoA ligase Mycobacterial subgroup FadD193963021CGVal222LeuTranscriptional regulator, LacI family4172275TGMet67LeuMembrane proteins related to metalloendopeptidases[^3]

Upon sequencing BCG Sofia SL222 and after comparison with the BCG-1 Russian strain, we observed one synonymous (s) SNP in the gene coding for an uridylyltransferase, in addition to three inverted regions of 42,965 bp, 17,778 bp and 6,765 bp in length. Furthermore, by mapping the reads obtained from the Sofia strain to the genome of the Danish vaccine strain, we confirmed the presence of the 1.6 kb deletion described by Stefanova et al.[@B9] This deletion affects part of the gene coding for type II toxin-antitoxin system VapC family toxin, the gene for the antitoxin VapB48 and part of the glutamate - cysteine ligase gene.

The genome of BCG Danish 1331 was the last to be assembled by using a combination of Illumina and PacBio reads.[@B7] One advantage of performing PacBio sequencing is that it generates longer reads that improves detection of repeated regions and duplications. Upon sequencing, we observed five SNPs including four nsSNP and a stop codon ([Table III](#t3){ref-type="table"}). We also observed a deletion of five nucleotides in a SRPBCC family protein gene and two inversions of 26,170 bp and 7,565 bp.

TABLE IIINon-synonymous single nucleotide polymorphisms (SNPs) found in Bacillus Calmette Guerin (BCG) Danish when using assembly NZ_CP039850^*\**^ as a referencePositionNZ_CP039850BCG DanishAA changeGene593769CTGln323\*\*SDR family oxidoreductase2076695CAAla142SerM56 family metallopeptidase2500583TCHis260ArgSulfotransferase3745609GTSer434TyrPPE family protein3839864TGThr135ProIMP dehydrogenase[^4]

Genome assembly of BCG Pasteur presented a nsSNP in the GTP-binding protein Obg gen (Asn599Asp) and two inframe insertions of three nucleotides each in the genes coding for NADPH epimerase/NADPH dehydratase and a probable cutinase. We also found one inverted region of 31,516 pb.

*De novo* sequencing of genomes deposited in public databases becomes imperative as new sequencing technologies arise. Recently, Abdallah et al.[@B15] reviewed the genomes and transcriptomes of fourteen BCG vaccine strains and together with the work of Borgers on the Danish vaccine comprise the most recent studies in BCG strains genealogy. We announce the initial draft genome of four of the most common BCG vaccines licensed worldwide in an effort to contribute to the update of publicly available data. The comparative analysis of BCG strains remains of crucial importance to trace their divergence in terms of genetic sequence, transcription and proteomic profile and, subsequently, to describe possible variation in the protective efficacy.

*Accession numbers* - The reads of each genome have been deposited under SRA accession PRJNA575846, BioProject ID: PRJNA575846.
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[^2]: bp: base-pairs; %GC: guanine-cytosine content; CDS: coding sequences; tRNA: transfer RNA.

[^3]: *\**: accession number for the assembly of BCG Moreau reported by Gomes et al.^(6)^ A: adenine; G: guanine; C: cytosine; T: thymine; Glu: glutamic acid; Asp: aspartic acid; Gly: glycine; Pro: proline; Leu: leucine; Lys: lysine; Asn: asparagine; Val: valine; His: histidine; Gln: glutamine; Met: methionine; Arg: arginine; Thr: threonine; Ser: serine; Ala: alanine; Trp: tryptophan; Ile: isoleucine.

[^4]: *\**: accession number for the sequencing of BCG Danish reported by Borgers et al.^(7)^; \*\*: indicates a stop codon; A: adenine; G: guanine; C: cytosine; T: thymine; Gln: glutamine; Ala: alanine; Ser: serine; Thr: threonine; Pro: proline; Tyr: tyrosine.
